Photodynamic therapy for cutaneous hemangiosarcoma in dogs

Area of Science:

• Veterinary Oncology
• Dermatology
• Photochemistry

Background:

• Cutaneous hemangiosarcoma is a common canine malignancy requiring aggressive treatment.
• Surgical excision, while effective, can be disfiguring.
• Photodynamic therapy (PDT) presents a potential non-mutilating alternative.

Purpose of the Study:

• To evaluate the efficacy and safety of PDT using aluminium-chloride-phthalocyanine nanoemulsion (AlClPc-nano) for treating canine cutaneous hemangiosarcoma.
• To determine the remission rates and potential adverse effects of this novel therapeutic approach.

Main Methods:

• Eight dogs with confirmed cutaneous hemangiosarcoma received intra/peritumoral AlClPc-nano injections.
• Tumors were subsequently irradiated with specific wavelength LED light.
• PDT sessions were repeated weekly until macroscopic resolution, followed by excisional biopsy and hematological analysis.

Main Results:

• Complete neoplastic remission was observed in seven out of eight treated dogs.
• Histopathology of excisional biopsies confirmed tumor necrosis and absence of cancer cells in most cases.
• No significant alterations in hematological parameters or organ function were detected post-treatment.

Conclusions:

• PDT utilizing AlClPc-nano is a safe and effective treatment modality for canine cutaneous hemangiosarcoma.
• This therapy offers a viable alternative to surgery, achieving high remission rates with minimal side effects.